NCT04709523

Guided Bone Regeneration Using Bovine-derived Xenograft in Combination With or Without Injectable Platelet-rich Fibrin

Name: Clinical Trial NCT04709523
Creator: Ege University
Keywords: Bone Resorption, bovine-derived xenograft with i-PRF, procedure, clinical trial

Guided Bone Regeneration Using Bovine-derived Xenograft in Combination With or Without Injectable Platelet-rich Fibrin: a Randomized-controlled Clinical Trial

Ege University·ClinicalTrials.gov·procedureCompleted

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Bone Resorption
Drug/Device/Intervention: bovine-derived xenograft with i-PRF
Study type: Interventional
Intervention type: procedure

Sponsor & location

Primary sponsor: Ege University

Timeline & enrollment

Phase: N/A
Start date: Jan 04, 2017
End date: Nov 23, 2020
Enrollment: 40 participants

Primary outcome

Augmentation thickness

Summary

The aim of the study was to compare the change in augmentation thickness after guided bone regeneration (GBR) using bovine-derived xenograft in combination with or without injectable platelet-rich fibrin (i-PRF).  This randomized-controlled clinical trial was conducted on patients with horizontal bone deficiency in the posterior regions of mandible. After implant placement, GBR procedures were randomly performed using i-PRF enriched bovine-derived xenograft (test group) or bovine derived xenograft alone (control group). Cone-beam computed tomography was taken at the implant sites immediately, and 6 months after surgery for assess the change in augmentation thickness as the primary outcome of the study. The secondary outcomes included marginal bone level and implant survival rate.

ICD-10 classifications

OsteolysisPathological resorption of teethBone donorPostsurgical malabsorption osteoporosisPostsurgical malabsorption osteoporosis with pathological fracture

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT04709523
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT04709523 through Pure Global AI's free database. This phase not specified trial is sponsored by Ege University and is currently Completed. The study focuses on Bone Resorption. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.